Literature DB >> 11844482

Lactate administration attenuates cognitive deficits following traumatic brain injury.

Ann C Rice1, Robert Zsoldos, Tao Chen, Margaret S Wilson, B Alessandri, Robert J Hamm, M Ross Bullock.   

Abstract

Moderately head injured patients often suffer long term neurological sequelae. There is no therapy for brain trauma and current treatments aim only to minimize secondary damage. These secondary effects are often triggered by the inability to re-establish ionic homeostasis after injury, due to large energy demands. Recent reports have demonstrated that neurons are capable of utilizing lactate as an energy source, thus this report examines the usefulness of lactate administration in the attenuation of behavioural deficits following a moderate brain injury. Lactate infusion (i.v.) was started 30 min after lateral fluid percussion injury and continued for 3 h. Cognitive deficits were determined using the Morris water maze. Lactate infused injured animals demonstrated significantly less cognitive deficits than saline infused injured animals. Thus, lactate infusion attenuated the cognitive deficits normally observed in this model, and therefore may provide moderately head injured patients with a treatment to help ameliorate the sequelae.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11844482     DOI: 10.1016/s0006-8993(01)03299-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  44 in total

1.  Glucose administration after traumatic brain injury improves cerebral metabolism and reduces secondary neuronal injury.

Authors:  Nobuhiro Moro; Sima Ghavim; Neil G Harris; David A Hovda; Richard L Sutton
Journal:  Brain Res       Date:  2013-08-29       Impact factor: 3.252

2.  Sodium lactate versus mannitol in the treatment of intracranial hypertensive episodes in severe traumatic brain-injured patients.

Authors:  Carole Ichai; Guy Armando; Jean-Christophe Orban; Frederic Berthier; Laurent Rami; Corine Samat-Long; Dominique Grimaud; Xavier Leverve
Journal:  Intensive Care Med       Date:  2008-09-20       Impact factor: 17.440

3.  Lactate clearance metrics are not superior to initial lactate in predicting mortality in trauma.

Authors:  S E Dekker; H-M de Vries; W D Lubbers; P M van de Ven; E J Toor; F W Bloemers; L M G Geeraedts; P Schober; C Boer
Journal:  Eur J Trauma Emerg Surg       Date:  2016-10-13       Impact factor: 3.693

4.  Lactate storm marks cerebral metabolism following brain trauma.

Authors:  Sanju Lama; Roland N Auer; Randy Tyson; Clare N Gallagher; Boguslaw Tomanek; Garnette R Sutherland
Journal:  J Biol Chem       Date:  2014-05-21       Impact factor: 5.157

5.  Pyruvate treatment attenuates cerebral metabolic depression and neuronal loss after experimental traumatic brain injury.

Authors:  Nobuhiro Moro; Sima S Ghavim; Neil G Harris; David A Hovda; Richard L Sutton
Journal:  Brain Res       Date:  2016-04-06       Impact factor: 3.252

Review 6.  A Perspective on the Müller Cell-Neuron Metabolic Partnership in the Inner Retina.

Authors:  A K Toft-Kehler; D M Skytt; Miriam Kolko
Journal:  Mol Neurobiol       Date:  2017-09-19       Impact factor: 5.590

Review 7.  A review of perioperative glucose control in the neurosurgical population.

Authors:  Joshua H Atkins; David S Smith
Journal:  J Diabetes Sci Technol       Date:  2009-11-01

Review 8.  Lactate: More Than Merely a Metabolic Waste Product in the Inner Retina.

Authors:  Rupali Vohra; Miriam Kolko
Journal:  Mol Neurobiol       Date:  2020-01-08       Impact factor: 5.590

9.  Glucose administration after traumatic brain injury exerts some benefits and no adverse effects on behavioral and histological outcomes.

Authors:  Katsunori Shijo; Sima Ghavim; Neil G Harris; David A Hovda; Richard L Sutton
Journal:  Brain Res       Date:  2015-04-21       Impact factor: 3.252

10.  Half-molar sodium-lactate solution has a beneficial effect in patients after coronary artery bypass grafting.

Authors:  Xavier M Leverve; Cindy Boon; Tarmizi Hakim; Maizul Anwar; Erwin Siregar; Iqbal Mustafa
Journal:  Intensive Care Med       Date:  2008-06-18       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.